Zheng-Jun Yang
Overview
Explore the profile of Zheng-Jun Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao X, Dai Y, Zhang Y, Yang M, Xie J, Chen G, et al.
World J Clin Cases
. 2024 Mar;
12(7):1215-1226.
PMID: 38524522
Background: Although the etiology of nonalcoholic fatty liver disease (NAFLD) has not been thoroughly understood, the emerging roles of anthropometric indicators in assessing and predicting the risk of NAFLD have...
2.
Yang Z, Xin F, Chen Z, Yu Y, Wang X, Cao X
BMC Cancer
. 2024 Jan;
24(1):134.
PMID: 38273267
Background: Neoadjuvant chemotherapy with dual-targeted therapy is the standard treatment for human epidermal growth factor 2 (HER2)-positive breast cancer. Although the dual-targeted therapy has significantly improved the pathological complete response...
3.
Yang Z, Liu Y, Huang Y, Chen Z, Zhang H, Yu Y, et al.
Cancer Med
. 2022 Aug;
12(3):2493-2504.
PMID: 35909232
Background: Breast cancer (BC) remains the leading cause of cancer-related deaths worldwide. High recurrence risk Luminal BC receives adjuvant chemotherapy in addition to standard hormone therapy. Considering the heterogeneity of...
4.
Liu B, Chen L, Ma K, Chi J, Yang Z, Yu Y, et al.
J Cancer Res Ther
. 2022 Jun;
18(2):496-502.
PMID: 35645120
Background: Radiotherapy is a practical locoregional treatment approach for women with breast cancer who show ipsilateral supraclavicular lymph node metastasis (ISLNM) on diagnosis. However, there is controversy around the role...
5.
Wang N, Yang Z, Wang X, Chen L, Zhao H, Cao W, et al.
Breast Cancer
. 2018 Apr;
25(6):629-638.
PMID: 29696563
Background: Molecular subtype of breast cancer is associated with sentinel lymph node status. We sought to establish a mathematical prediction model that included breast cancer molecular subtype for risk of...
6.
Yu Y, Luo W, Yang Z, Chi J, Li Y, Ding Y, et al.
Mol Cancer
. 2018 Mar;
17(1):70.
PMID: 29510731
Background: Breast cancer is the most common cancer among women worldwide and metastasis is the leading cause of death among patients with breast cancer. The transforming growth factor-β (TGF-β) pathway...
7.
Yang Z, Yu Y, Chi J, Guan M, Zhao Y, Cao X
Breast Cancer
. 2018 Jan;
25(3):315-324.
PMID: 29353447
Background: pN stage and breast cancer subtypes (BCS) are both well-recognized prognostic indicators. Our previous work has highlighted that patients even with the same pN stage exhibited a significant survival...
8.
Fang J, Ma L, Zhang Y, Yang Z, Yu Y, Cao X
Surg Oncol
. 2017 Nov;
26(4):338-344.
PMID: 29113649
Background: Our purpose was to present a new method of endoscopic sentinel lymph node biopsy (ESLNB) and endoscopic axillary lymphadenectomy (EALND) without liposuction for treating early-stage breast cancer, and compare...
9.
Ge J, Yu Y, Xin F, Yang Z, Zhao H, Wang X, et al.
Cancer Sci
. 2017 Apr;
108(4):604-611.
PMID: 28403546
Delta-aminolevulinate dehydratase (ALAD) catalyzes the second step in the biosynthesis of heme and is also an endogenous inhibitor of the 26S proteasome. The role of ALAD in breast cancer progression...
10.
Yang Z, Yu Y, Hou X, Chi J, Ge J, Wang X, et al.
Oncotarget
. 2016 Dec;
8(3):4563-4571.
PMID: 27999188
Nodal metastases and breast cancer subtypes (BCS) are both well-recognized prognostic indicators. However, the association between nodal metastases and BCS, and the prognostic value of nodal metastases in different BCS...